Monitoring of the Immune Dysfunction in Cancer Patients
Immunotherapy shows promising clinical results in patients with different types of cancer, but its full potential is not reached due to immune dysfunction as a result of several suppressive mechanisms that play a role in cancer development and progression. Monitoring of immune dysfunction is a prere...
Main Authors: | Santegoets, Saskia J. A. M., Welters, Marij J. P., van der Burg, Sjoerd H. |
---|---|
Format: | Online |
Language: | English |
Published: |
MDPI
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041023/ |
Similar Items
-
Detection and functional assessment of regulatory T cells in clinical samples
by: Santegoets, Saskia, et al.
Published: (2014) -
EGFR signaling suppresses type 1 cytokine-induced T-cell attracting chemokine secretion in head and neck cancer.
by: Wenbo Ma, et al. -
Managing Multi-center Flow Cytometry Data for Immune Monitoring
by: White, Scott, et al.
Published: (2015) -
Human papillomavirus 16-specific cell-mediated immunity in children born to mothers with incident cervical intraepithelial neoplasia (CIN) and to those constantly HPV negative
by: Koskimaa, Hanna-Mari, et al.
Published: (2015) -
Local and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma
by: Talebian Yazdi, Mehrdad, et al.
Published: (2015)